PRMT6 gain‐of‐function cells exhibited augmented proliferation and colony numbers, while PRMT6 depletion decreased these effects in the triple‐negative cell line MDA‐MB‐231 and luminal breast cancer cell line MCF‐7 cells (Figure 2E–G). Here, PRMT6 is linked to breast carcinoma.